# ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

> **NCT03334240** · PHASE2 · TERMINATED · sponsor: **Maruho Co., Ltd.** · enrollment: 28 (actual)

## Conditions studied

- HPV-Induced Genital Lesions

## Interventions

- **DRUG:** CLS003
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03334240
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-05
- **Primary completion:** 2018-10-30
- **Final completion:** 2018-10-30
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Lack of effect in interim analysis
- **Last updated:** 2019-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334240, "ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03334240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*